Biotech News

Medpace Holdings, Inc. Reports First Quarter 2025 Results

investor.medpace.com2026-05-06 14:45 EST

Revenue of $558.6 million in the first quarter of 2025 increased 9.3% from revenue of $511.0 million for the comparable prior-year period, representing a backlog conversion rate of 19.2%. Net new business awards were $500.0 million in the first quarter of 2025, representing a decrease of 18.8% from

Full article